[Specific treatment of excessive iron deposition in the tissues].
D000284:Administration, Oral; D001815:Bloodletting; D002614:Chelating Agents / Q000627:therapeutic use; D003238:Connective Tissue / Q000378:metabolism; D003676:Deferoxamine / Q000008:administration & dosage / Q000378:metabolism; D006432:Hemochromatosis / Q000188:drug therapy / Q000378:metabolism; D006486:Hemosiderosis / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007501:Iron / Q000378:metabolism / Q000652:urine; D007502:Iron Chelating Agents / Q000378:metabolism; D012806:Siderosis / Q000378:metabolism / Q000628:therapy; D014168:Transferrin / Q000378:metabolism
D002614:Chelating Agents; D007502:Iron Chelating Agents; D014168:Transferrin; D007501:Iron; D003676:Deferoxamine
Swoiste leczenie nadmiernego odkładania zelaza w ustroju.